Congratulations! The decision to embark on the journey of founding a biopharmaceutical company is a courageous step indeed. Remember, as Tony Wheeler put it, “All you’ve got to do is decide to go and the hardest part is over.” Yet this venture is less of a sprint and more of Read more…
“I got diagnosed in my early 20s” “I wanted to so badly say, ‘You guys have no idea. I’m in chemotherapy. You’re a–holes.’ I locked myself away until I was confident and comfortable again,” (despite of sparked rumors of addiction.) “had to take a break from my career last year to deal with Read more…
online payment, credit card payment, fast services
Humira, a top-selling drug with $200 billion in revenue over two decades, recently lost its patent monopoly. This paved the way for biosimilars like Amjevita to enter the market and offer more affordable treatment options. However, when Amgen launched Amjevita in the US, it had two list prices, $40,500 (55% Read more…
Artificial intelligence (AI), machine learning (ML), deep learning (DL), and natural language processing (NLP) are hard-to-avoid buzzwords at professional conferences, scientific journals, technological news, social media, and, of course, any vendor’s marketing pitch. Many enthusiasts have even made the splash in media that AI is going to revolutionize everything and Read more…